IOL Chemicals and Pharmaceuticals Limited
IOLCP.NS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$48.18B
Close$
$-27.82
115.4% downside
Current Fair Value
115.4% downsideOvervalued by 115.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $48.18 Billion |
|---|---|
| Enterprise Value | $48.18 Billion |
| Annual dividend | $1.00 |
| Dividend yield | 0.61% |
| Earnings per Share | $4.69 |
| Beta | 0.48 |
| Outstanding Shares | 293,527,510 |
Return
| Return on Equity | 9.35% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 28.7 |
|---|---|
| PEG | 31.95 |
| Price to Sales | 2.12 |
| Price to Book Ratio | 2.96 |
| Enterprise Value to Revenue | 1.91 |
| Enterprise Value to EBIT | 20.83 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$6.47 B
Consensus analyst estimateNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$7.60 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About IOL Chemicals and Pharmaceuticals Limited
3,592 employees
CEO: Varinder Gupta
IOL Chemicals and Pharmaceuticals Limited is a global manufacturer and supplier of a diverse range of pharmaceutical and chemical products. The company’s pharmaceutical portfolio focuses on Active Pharmaceutical Ingredients (APIs), provi...